Enhanced Recovery after Pediatric Cardiac Surgery: A Meta-Analysis

Osama Abu-Shawer1, Abdel-Rahman E'mar2, Abdel-Rahman Jaber3

  • 1Anesthesiology and Perioperative Medicine, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States.

PubMed

Insights

Enhanced Recovery After Surgery (ERAS) protocols in pediatric cardiac surgery reduce ICU length of stay but do not significantly alter complication rates. Further research is needed to confirm efficacy and long-term benefits.

Area of Science:

  • Pediatric Cardiac Surgery
  • Enhanced Recovery After Surgery (ERAS) Protocols
  • Systematic Review and Meta-Analysis

Background:

  • Enhanced Recovery After Surgery (ERAS) protocols are established multimodal perioperative care pathways.
  • Application of ERAS in pediatric cardiac surgery is emerging.
  • This study systematically reviews the efficacy of ERAS in pediatric cardiac surgery.

Purpose of the Study:

  • To systematically review the current evidence on the efficacy of ERAS protocols in pediatric cardiac surgery.
  • To evaluate the impact of ERAS on postoperative outcomes in pediatric cardiac surgery patients.
  • To identify gaps in the existing literature regarding ERAS implementation in this population.

Main Methods:

  • A systematic review and meta-analysis were conducted following PRISMA guidelines.
  • Searched multiple databases (PubMed, Cochrane, Scopus, etc.) for comparative studies from 2000-2024.
  • Included five studies (3 RCTs, 1 cohort, 1 case-control) with 1,008 pediatric cardiac surgery patients.

Main Results:

  • ERAS implementation significantly reduced Intensive Care Unit (ICU) length of stay (MD = -1.441 days, p=0.016).
  • No significant difference in postoperative complication rates between ERAS and standard care groups (OR = 0.889, p=0.516).
  • Heterogeneity was high for ICU length of stay (I²=98.26%).

Conclusions:

  • ERAS protocols show promise for improving short-term outcomes, specifically reducing ICU stay, in pediatric cardiac surgery.
  • Current evidence is limited by the small number of studies and heterogeneity.
  • Further high-quality, multicenter randomized controlled trials are necessary to fully assess ERAS efficacy and long-term outcomes.
Abstract